Brazilian multicenter study on pegvisomant treatment in acromegaly
César Luiz Boguszewski +14 more
openalex +1 more source
Growth Hormone Upregulates Melanoma Drug Resistance and Migration via Melanoma-Derived Exosomes. [PDF]
Kulkarni P +5 more
europepmc +1 more source
Long-term Pegvisomant Therapy of Acromegaly: Effects on Bone Density, Turnover and Microstructure Using HRpQCT. [PDF]
Kuker AP +10 more
europepmc +1 more source
A Review on Coexisting Giants: The Interplay Between Acromegaly and Diabetes Mellitus. [PDF]
Aggarwal S +4 more
europepmc +1 more source
Assessment of the therapeutic value of new medicines marketed in Australia [PDF]
core +1 more source
Predicting Response to Medical Treatment in Acromegaly via Granulation Pattern, Expression of Somatostatin Receptors Type 2 and 5 and E-Cadherin. [PDF]
Gliga MC, Chinezu L, Pascanu IM.
europepmc +1 more source
Insights from an Italian Delphi panel: exploring resistance to first-generation somatostatin receptor ligands and guiding second-line medical therapies in acromegaly management. [PDF]
Grottoli S +6 more
europepmc +1 more source
ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs
Marta Araujo‐Castro +46 more
openalex +1 more source
Case Report: Bilateral lens dislocation as an atypical presentation of acromegaly and review of the ocular effects of GH/IGF-1 excess. [PDF]
Vitale L +6 more
europepmc +1 more source

